NewsSTAT

Ranked by formulaVerdict: Routine

STAT+: Tango builds on Revolution Medicines' pancreatic cancer success

Original title: STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success

As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna and Merck's cancer vaccine is released early.

By Keshavan, Wosen

Score█████░░░░░5.1

VerdictCompetent work. Briefs at most.

Read at STAT

Summary from the source

As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna and Merck's cancer vaccine is released early.

Meghana Keshavan, Jonathan Wosen

The editor's rubric

Heuristic review

Leverage2 / 5
Reusable within one subfield (a technique, dataset, or protocol a few groups will adopt).
15% of this desk’s rubric
Magnitude2 / 5
Solid incremental gain on a meaningful problem.
20% of this desk’s rubric
Evidence2 / 5
Limited: single setting, weak baselines, or an observational association presented as causal.
20% of this desk’s rubric
Novelty2 / 5
A new combination of known ideas.
10% of this desk’s rubric
Trajectory2 / 5
Some room to improve with obvious engineering.
10% of this desk’s rubric
Stakes3 / 5
Meaningful benefit to many people within a few years.
25% of this desk’s rubric

Editor’s rationale

Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: verification (error bars); stakes (major disease, prevention or cure).

How the score was computed

rank-2026-10-18

Score█████░░░░░5.1

Score = 10 × (50% × adjusted merit / 10 + 25% × attention + 25% × freshness)

Desks place stronger verdicts first, then use this score to order work within the same verdict.

Merit
3.8 / 10
Weighted rubric, evidence-gated.
Adjusted merit
3.9 / 10
Shrunk toward the desk prior by editor confidence (30%).
Attention
28%
Citations, upvotes, points, mentions.
Freshness
98%
Half-life decay since publication.

No attention signals recorded yet.

The record

  • Reviewed by heuristic-v7 on Oct 23, 2026, 15:54 UTC. Paper type: news.
  • Categories: Biotech, Business, Pharma, The Readout, biotechnology, drug development, research, STAT+
  • BRIEF, No.3 in the Front page edition of October 23, 2026.
  • TOP, No.2 in the News edition of October 23, 2026.